Company Overview
About Cytovale
Cytovale is a medical technology company headquartered in San Francisco, California, founded in 2014 by Lydia Sohn and others, with roots in biophysics research at the University of California, Berkeley. The company is developing the IntelliSep test — a rapid, near-patient diagnostic for sepsis that uses a proprietary microfluidic technology to measure the mechanical properties (deformability) of immune cells in whole blood. Sepsis — a life-threatening systemic immune response to infection — kills approximately 270,000 Americans annually and is the leading cause of hospital mortality, yet current diagnostic approaches (blood cultures, lactate, clinical scoring systems) are slow, non-specific, and frequently fail to identify sepsis before it progresses to organ failure and septic shock.
Business Model & Competitive Advantage
IntelliSep works by flowing a small whole blood sample through a microfluidic chip where neutrophils (key immune cells) are squeezed through defined constrictions. Sepsis causes measurable changes in neutrophil cell mechanics — septic neutrophils become more deformable (softer) than healthy neutrophils due to cytoskeletal changes driven by sepsis pathophysiology. Cytovale's system measures these biophysical changes to generate an IntelliSep Index score within approximately 8 minutes at the point of care, providing emergency physicians with an objective sepsis likelihood score to guide early treatment decisions. The test has received FDA Breakthrough Device Designation, reflecting the agency's assessment that it addresses an unmet medical need.
Competitive Landscape 2025–2026
Cytovale raised $88M in total funding across multiple rounds, with investors including Khosla Ventures, Greycroft, Triventures, and other healthcare and life sciences investors. The company competes in the sepsis diagnostics market against Inflammatix (host-gene expression sepsis test), BioMérieux (blood culture and procalcitonin testing), and clinical AI decision support tools. Cytovale's differentiation is the speed (8-minute turnaround versus 24–72 hours for blood culture), the non-culture-based mechanism, and the point-of-care deployment model suitable for emergency department workflows.
Key Differentiators
Emerging Innovator
Cytovale is an emerging player bringing innovative solutions to the Healthcare market.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Oracle Health
Oracle Health is the healthcare technology business unit of Oracle Corporation (NYSE: ORCL) — providing electronic health records (EHR), clinical workflow management, health information exchange, reve
Doximity
Doximity is a professional network and digital health platform purpose-built for licensed physicians and other healthcare professionals in the United States. With more than two million verified clinic
Headspace
Headspace is a mental wellness company founded in 2010 by Andy Puddicombe and Rich Pierson that has grown into one of the most widely used mindfulness and meditation apps globally. The platform offers
Zocdoc
Zocdoc operates a two-sided marketplace connecting patients with physicians, dentists, and mental health providers who accept their specific insurance and have real-time appointment availability. Pati
Noom
Noom is a digital health company founded in 2008 that has grown into one of the most widely used weight management platforms, serving millions of members through its psychology-driven approach to beha
Epic Systems
Epic Systems Corporation was founded in 1979 by Judith Faulkner and is headquartered in Verona, Wisconsin, remaining privately held with Faulkner as majority owner. The company develops large-scale el
Compare Cytovale with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Cytovale? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Cytovale Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Cytovale vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →